Global Pharmacokinetics Services Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Pharmacokinetics Services Market Size was estimated at USD 673.09 million in 2023 and is projected to reach USD 886.66 million by 2029, exhibiting a CAGR of 4.70% during the forecast period.
This report provides a deep insight into the global Pharmacokinetics Services market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pharmacokinetics Services Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pharmacokinetics Services market in any manner.
Global Pharmacokinetics Services Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Evotec AG (Germany)
Pacific BioLabs (US)
GVK Biosciences Private Limited (India)
Shanghai Medicilon Inc. (China)
Pharmaceutical Product Development, LLC (US)
Charles River Laboratories International, Inc. (US)
PAREXEL International Corporation (US)
Eurofins Scientific, Inc. (Luxembourg)
Frontage Labs (US)
SGS SA (Switzerland)
LGC Limited (UK)
Creative Bioarray (US)
Certara, L.P. (Germany)
Market Segmentation (by Type)
Small Molecules Pharmacokinetics Services
Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
Market Segmentation (by Application)
Small & Medium Enterprise
Large Enterprise
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmacokinetics Services Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Pharmacokinetics Services Market Size was estimated at USD 673.09 million in 2023 and is projected to reach USD 886.66 million by 2029, exhibiting a CAGR of 4.70% during the forecast period.
This report provides a deep insight into the global Pharmacokinetics Services market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pharmacokinetics Services Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pharmacokinetics Services market in any manner.
Global Pharmacokinetics Services Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Evotec AG (Germany)
Pacific BioLabs (US)
GVK Biosciences Private Limited (India)
Shanghai Medicilon Inc. (China)
Pharmaceutical Product Development, LLC (US)
Charles River Laboratories International, Inc. (US)
PAREXEL International Corporation (US)
Eurofins Scientific, Inc. (Luxembourg)
Frontage Labs (US)
SGS SA (Switzerland)
LGC Limited (UK)
Creative Bioarray (US)
Certara, L.P. (Germany)
Market Segmentation (by Type)
Small Molecules Pharmacokinetics Services
Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
Market Segmentation (by Application)
Small & Medium Enterprise
Large Enterprise
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Pharmacokinetics Services Market
- Overview of the regional outlook of the Pharmacokinetics Services Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmacokinetics Services Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Pharmacokinetics Services
1.2 Key Market Segments
1.2.1 Pharmacokinetics Services Segment by Type
1.2.2 Pharmacokinetics Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PHARMACOKINETICS SERVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pharmacokinetics Services Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pharmacokinetics Services Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PHARMACOKINETICS SERVICES MARKET COMPETITIVE LANDSCAPE
3.1 Global Pharmacokinetics Services Sales by Manufacturers (2019-2024)
3.2 Global Pharmacokinetics Services Revenue Market Share by Manufacturers (2019-2024)
3.3 Pharmacokinetics Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pharmacokinetics Services Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pharmacokinetics Services Sales Sites, Area Served, Product Type
3.6 Pharmacokinetics Services Market Competitive Situation and Trends
3.6.1 Pharmacokinetics Services Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pharmacokinetics Services Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PHARMACOKINETICS SERVICES INDUSTRY CHAIN ANALYSIS
4.1 Pharmacokinetics Services Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PHARMACOKINETICS SERVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PHARMACOKINETICS SERVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmacokinetics Services Sales Market Share by Type (2019-2024)
6.3 Global Pharmacokinetics Services Market Size Market Share by Type (2019-2024)
6.4 Global Pharmacokinetics Services Price by Type (2019-2024)
7 PHARMACOKINETICS SERVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmacokinetics Services Market Sales by Application (2019-2024)
7.3 Global Pharmacokinetics Services Market Size (M USD) by Application (2019-2024)
7.4 Global Pharmacokinetics Services Sales Growth Rate by Application (2019-2024)
8 PHARMACOKINETICS SERVICES MARKET SEGMENTATION BY REGION
8.1 Global Pharmacokinetics Services Sales by Region
8.1.1 Global Pharmacokinetics Services Sales by Region
8.1.2 Global Pharmacokinetics Services Sales Market Share by Region
8.2 North America
8.2.1 North America Pharmacokinetics Services Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pharmacokinetics Services Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pharmacokinetics Services Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pharmacokinetics Services Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pharmacokinetics Services Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Evotec AG (Germany)
9.1.1 Evotec AG (Germany) Pharmacokinetics Services Basic Information
9.1.2 Evotec AG (Germany) Pharmacokinetics Services Product Overview
9.1.3 Evotec AG (Germany) Pharmacokinetics Services Product Market Performance
9.1.4 Evotec AG (Germany) Business Overview
9.1.5 Evotec AG (Germany) Pharmacokinetics Services SWOT Analysis
9.1.6 Evotec AG (Germany) Recent Developments
9.2 Pacific BioLabs (US)
9.2.1 Pacific BioLabs (US) Pharmacokinetics Services Basic Information
9.2.2 Pacific BioLabs (US) Pharmacokinetics Services Product Overview
9.2.3 Pacific BioLabs (US) Pharmacokinetics Services Product Market Performance
9.2.4 Pacific BioLabs (US) Business Overview
9.2.5 Pacific BioLabs (US) Pharmacokinetics Services SWOT Analysis
9.2.6 Pacific BioLabs (US) Recent Developments
9.3 GVK Biosciences Private Limited (India)
9.3.1 GVK Biosciences Private Limited (India) Pharmacokinetics Services Basic Information
9.3.2 GVK Biosciences Private Limited (India) Pharmacokinetics Services Product Overview
9.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Product Market Performance
9.3.4 GVK Biosciences Private Limited (India) Pharmacokinetics Services SWOT Analysis
9.3.5 GVK Biosciences Private Limited (India) Business Overview
9.3.6 GVK Biosciences Private Limited (India) Recent Developments
9.4 Shanghai Medicilon Inc. (China)
9.4.1 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Basic Information
9.4.2 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Product Overview
9.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Product Market Performance
9.4.4 Shanghai Medicilon Inc. (China) Business Overview
9.4.5 Shanghai Medicilon Inc. (China) Recent Developments
9.5 Pharmaceutical Product Development, LLC (US)
9.5.1 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Basic Information
9.5.2 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Product Overview
9.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Product Market Performance
9.5.4 Pharmaceutical Product Development, LLC (US) Business Overview
9.5.5 Pharmaceutical Product Development, LLC (US) Recent Developments
9.6 Charles River Laboratories International, Inc. (US)
9.6.1 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Basic Information
9.6.2 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Product Overview
9.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Product Market Performance
9.6.4 Charles River Laboratories International, Inc. (US) Business Overview
9.6.5 Charles River Laboratories International, Inc. (US) Recent Developments
9.7 PAREXEL International Corporation (US)
9.7.1 PAREXEL International Corporation (US) Pharmacokinetics Services Basic Information
9.7.2 PAREXEL International Corporation (US) Pharmacokinetics Services Product Overview
9.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Product Market Performance
9.7.4 PAREXEL International Corporation (US) Business Overview
9.7.5 PAREXEL International Corporation (US) Recent Developments
9.8 Eurofins Scientific, Inc. (Luxembourg)
9.8.1 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Basic Information
9.8.2 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Product Overview
9.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Product Market Performance
9.8.4 Eurofins Scientific, Inc. (Luxembourg) Business Overview
9.8.5 Eurofins Scientific, Inc. (Luxembourg) Recent Developments
9.9 Frontage Labs (US)
9.9.1 Frontage Labs (US) Pharmacokinetics Services Basic Information
9.9.2 Frontage Labs (US) Pharmacokinetics Services Product Overview
9.9.3 Frontage Labs (US) Pharmacokinetics Services Product Market Performance
9.9.4 Frontage Labs (US) Business Overview
9.9.5 Frontage Labs (US) Recent Developments
9.10 SGS SA (Switzerland)
9.10.1 SGS SA (Switzerland) Pharmacokinetics Services Basic Information
9.10.2 SGS SA (Switzerland) Pharmacokinetics Services Product Overview
9.10.3 SGS SA (Switzerland) Pharmacokinetics Services Product Market Performance
9.10.4 SGS SA (Switzerland) Business Overview
9.10.5 SGS SA (Switzerland) Recent Developments
9.11 LGC Limited (UK)
9.11.1 LGC Limited (UK) Pharmacokinetics Services Basic Information
9.11.2 LGC Limited (UK) Pharmacokinetics Services Product Overview
9.11.3 LGC Limited (UK) Pharmacokinetics Services Product Market Performance
9.11.4 LGC Limited (UK) Business Overview
9.11.5 LGC Limited (UK) Recent Developments
9.12 Creative Bioarray (US)
9.12.1 Creative Bioarray (US) Pharmacokinetics Services Basic Information
9.12.2 Creative Bioarray (US) Pharmacokinetics Services Product Overview
9.12.3 Creative Bioarray (US) Pharmacokinetics Services Product Market Performance
9.12.4 Creative Bioarray (US) Business Overview
9.12.5 Creative Bioarray (US) Recent Developments
9.13 Certara, L.P. (Germany)
9.13.1 Certara, L.P. (Germany) Pharmacokinetics Services Basic Information
9.13.2 Certara, L.P. (Germany) Pharmacokinetics Services Product Overview
9.13.3 Certara, L.P. (Germany) Pharmacokinetics Services Product Market Performance
9.13.4 Certara, L.P. (Germany) Business Overview
9.13.5 Certara, L.P. (Germany) Recent Developments
10 PHARMACOKINETICS SERVICES MARKET FORECAST BY REGION
10.1 Global Pharmacokinetics Services Market Size Forecast
10.2 Global Pharmacokinetics Services Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pharmacokinetics Services Market Size Forecast by Country
10.2.3 Asia Pacific Pharmacokinetics Services Market Size Forecast by Region
10.2.4 South America Pharmacokinetics Services Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pharmacokinetics Services by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Pharmacokinetics Services Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pharmacokinetics Services by Type (2025-2030)
11.1.2 Global Pharmacokinetics Services Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pharmacokinetics Services by Type (2025-2030)
11.2 Global Pharmacokinetics Services Market Forecast by Application (2025-2030)
11.2.1 Global Pharmacokinetics Services Sales (K Units) Forecast by Application
11.2.2 Global Pharmacokinetics Services Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Pharmacokinetics Services
1.2 Key Market Segments
1.2.1 Pharmacokinetics Services Segment by Type
1.2.2 Pharmacokinetics Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PHARMACOKINETICS SERVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pharmacokinetics Services Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pharmacokinetics Services Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PHARMACOKINETICS SERVICES MARKET COMPETITIVE LANDSCAPE
3.1 Global Pharmacokinetics Services Sales by Manufacturers (2019-2024)
3.2 Global Pharmacokinetics Services Revenue Market Share by Manufacturers (2019-2024)
3.3 Pharmacokinetics Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pharmacokinetics Services Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pharmacokinetics Services Sales Sites, Area Served, Product Type
3.6 Pharmacokinetics Services Market Competitive Situation and Trends
3.6.1 Pharmacokinetics Services Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pharmacokinetics Services Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PHARMACOKINETICS SERVICES INDUSTRY CHAIN ANALYSIS
4.1 Pharmacokinetics Services Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PHARMACOKINETICS SERVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PHARMACOKINETICS SERVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmacokinetics Services Sales Market Share by Type (2019-2024)
6.3 Global Pharmacokinetics Services Market Size Market Share by Type (2019-2024)
6.4 Global Pharmacokinetics Services Price by Type (2019-2024)
7 PHARMACOKINETICS SERVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmacokinetics Services Market Sales by Application (2019-2024)
7.3 Global Pharmacokinetics Services Market Size (M USD) by Application (2019-2024)
7.4 Global Pharmacokinetics Services Sales Growth Rate by Application (2019-2024)
8 PHARMACOKINETICS SERVICES MARKET SEGMENTATION BY REGION
8.1 Global Pharmacokinetics Services Sales by Region
8.1.1 Global Pharmacokinetics Services Sales by Region
8.1.2 Global Pharmacokinetics Services Sales Market Share by Region
8.2 North America
8.2.1 North America Pharmacokinetics Services Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pharmacokinetics Services Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pharmacokinetics Services Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pharmacokinetics Services Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pharmacokinetics Services Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Evotec AG (Germany)
9.1.1 Evotec AG (Germany) Pharmacokinetics Services Basic Information
9.1.2 Evotec AG (Germany) Pharmacokinetics Services Product Overview
9.1.3 Evotec AG (Germany) Pharmacokinetics Services Product Market Performance
9.1.4 Evotec AG (Germany) Business Overview
9.1.5 Evotec AG (Germany) Pharmacokinetics Services SWOT Analysis
9.1.6 Evotec AG (Germany) Recent Developments
9.2 Pacific BioLabs (US)
9.2.1 Pacific BioLabs (US) Pharmacokinetics Services Basic Information
9.2.2 Pacific BioLabs (US) Pharmacokinetics Services Product Overview
9.2.3 Pacific BioLabs (US) Pharmacokinetics Services Product Market Performance
9.2.4 Pacific BioLabs (US) Business Overview
9.2.5 Pacific BioLabs (US) Pharmacokinetics Services SWOT Analysis
9.2.6 Pacific BioLabs (US) Recent Developments
9.3 GVK Biosciences Private Limited (India)
9.3.1 GVK Biosciences Private Limited (India) Pharmacokinetics Services Basic Information
9.3.2 GVK Biosciences Private Limited (India) Pharmacokinetics Services Product Overview
9.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Product Market Performance
9.3.4 GVK Biosciences Private Limited (India) Pharmacokinetics Services SWOT Analysis
9.3.5 GVK Biosciences Private Limited (India) Business Overview
9.3.6 GVK Biosciences Private Limited (India) Recent Developments
9.4 Shanghai Medicilon Inc. (China)
9.4.1 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Basic Information
9.4.2 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Product Overview
9.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Product Market Performance
9.4.4 Shanghai Medicilon Inc. (China) Business Overview
9.4.5 Shanghai Medicilon Inc. (China) Recent Developments
9.5 Pharmaceutical Product Development, LLC (US)
9.5.1 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Basic Information
9.5.2 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Product Overview
9.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Product Market Performance
9.5.4 Pharmaceutical Product Development, LLC (US) Business Overview
9.5.5 Pharmaceutical Product Development, LLC (US) Recent Developments
9.6 Charles River Laboratories International, Inc. (US)
9.6.1 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Basic Information
9.6.2 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Product Overview
9.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Product Market Performance
9.6.4 Charles River Laboratories International, Inc. (US) Business Overview
9.6.5 Charles River Laboratories International, Inc. (US) Recent Developments
9.7 PAREXEL International Corporation (US)
9.7.1 PAREXEL International Corporation (US) Pharmacokinetics Services Basic Information
9.7.2 PAREXEL International Corporation (US) Pharmacokinetics Services Product Overview
9.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Product Market Performance
9.7.4 PAREXEL International Corporation (US) Business Overview
9.7.5 PAREXEL International Corporation (US) Recent Developments
9.8 Eurofins Scientific, Inc. (Luxembourg)
9.8.1 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Basic Information
9.8.2 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Product Overview
9.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Product Market Performance
9.8.4 Eurofins Scientific, Inc. (Luxembourg) Business Overview
9.8.5 Eurofins Scientific, Inc. (Luxembourg) Recent Developments
9.9 Frontage Labs (US)
9.9.1 Frontage Labs (US) Pharmacokinetics Services Basic Information
9.9.2 Frontage Labs (US) Pharmacokinetics Services Product Overview
9.9.3 Frontage Labs (US) Pharmacokinetics Services Product Market Performance
9.9.4 Frontage Labs (US) Business Overview
9.9.5 Frontage Labs (US) Recent Developments
9.10 SGS SA (Switzerland)
9.10.1 SGS SA (Switzerland) Pharmacokinetics Services Basic Information
9.10.2 SGS SA (Switzerland) Pharmacokinetics Services Product Overview
9.10.3 SGS SA (Switzerland) Pharmacokinetics Services Product Market Performance
9.10.4 SGS SA (Switzerland) Business Overview
9.10.5 SGS SA (Switzerland) Recent Developments
9.11 LGC Limited (UK)
9.11.1 LGC Limited (UK) Pharmacokinetics Services Basic Information
9.11.2 LGC Limited (UK) Pharmacokinetics Services Product Overview
9.11.3 LGC Limited (UK) Pharmacokinetics Services Product Market Performance
9.11.4 LGC Limited (UK) Business Overview
9.11.5 LGC Limited (UK) Recent Developments
9.12 Creative Bioarray (US)
9.12.1 Creative Bioarray (US) Pharmacokinetics Services Basic Information
9.12.2 Creative Bioarray (US) Pharmacokinetics Services Product Overview
9.12.3 Creative Bioarray (US) Pharmacokinetics Services Product Market Performance
9.12.4 Creative Bioarray (US) Business Overview
9.12.5 Creative Bioarray (US) Recent Developments
9.13 Certara, L.P. (Germany)
9.13.1 Certara, L.P. (Germany) Pharmacokinetics Services Basic Information
9.13.2 Certara, L.P. (Germany) Pharmacokinetics Services Product Overview
9.13.3 Certara, L.P. (Germany) Pharmacokinetics Services Product Market Performance
9.13.4 Certara, L.P. (Germany) Business Overview
9.13.5 Certara, L.P. (Germany) Recent Developments
10 PHARMACOKINETICS SERVICES MARKET FORECAST BY REGION
10.1 Global Pharmacokinetics Services Market Size Forecast
10.2 Global Pharmacokinetics Services Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pharmacokinetics Services Market Size Forecast by Country
10.2.3 Asia Pacific Pharmacokinetics Services Market Size Forecast by Region
10.2.4 South America Pharmacokinetics Services Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pharmacokinetics Services by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Pharmacokinetics Services Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pharmacokinetics Services by Type (2025-2030)
11.1.2 Global Pharmacokinetics Services Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pharmacokinetics Services by Type (2025-2030)
11.2 Global Pharmacokinetics Services Market Forecast by Application (2025-2030)
11.2.1 Global Pharmacokinetics Services Sales (K Units) Forecast by Application
11.2.2 Global Pharmacokinetics Services Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pharmacokinetics Services Market Size Comparison by Region (M USD)
Table 5. Global Pharmacokinetics Services Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Pharmacokinetics Services Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pharmacokinetics Services Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pharmacokinetics Services Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacokinetics Services as of 2022)
Table 10. Global Market Pharmacokinetics Services Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pharmacokinetics Services Sales Sites and Area Served
Table 12. Manufacturers Pharmacokinetics Services Product Type
Table 13. Global Pharmacokinetics Services Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pharmacokinetics Services
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pharmacokinetics Services Market Challenges
Table 22. Global Pharmacokinetics Services Sales by Type (K Units)
Table 23. Global Pharmacokinetics Services Market Size by Type (M USD)
Table 24. Global Pharmacokinetics Services Sales (K Units) by Type (2019-2024)
Table 25. Global Pharmacokinetics Services Sales Market Share by Type (2019-2024)
Table 26. Global Pharmacokinetics Services Market Size (M USD) by Type (2019-2024)
Table 27. Global Pharmacokinetics Services Market Size Share by Type (2019-2024)
Table 28. Global Pharmacokinetics Services Price (USD/Unit) by Type (2019-2024)
Table 29. Global Pharmacokinetics Services Sales (K Units) by Application
Table 30. Global Pharmacokinetics Services Market Size by Application
Table 31. Global Pharmacokinetics Services Sales by Application (2019-2024) & (K Units)
Table 32. Global Pharmacokinetics Services Sales Market Share by Application (2019-2024)
Table 33. Global Pharmacokinetics Services Sales by Application (2019-2024) & (M USD)
Table 34. Global Pharmacokinetics Services Market Share by Application (2019-2024)
Table 35. Global Pharmacokinetics Services Sales Growth Rate by Application (2019-2024)
Table 36. Global Pharmacokinetics Services Sales by Region (2019-2024) & (K Units)
Table 37. Global Pharmacokinetics Services Sales Market Share by Region (2019-2024)
Table 38. North America Pharmacokinetics Services Sales by Country (2019-2024) & (K Units)
Table 39. Europe Pharmacokinetics Services Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Pharmacokinetics Services Sales by Region (2019-2024) & (K Units)
Table 41. South America Pharmacokinetics Services Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Pharmacokinetics Services Sales by Region (2019-2024) & (K Units)
Table 43. Evotec AG (Germany) Pharmacokinetics Services Basic Information
Table 44. Evotec AG (Germany) Pharmacokinetics Services Product Overview
Table 45. Evotec AG (Germany) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Evotec AG (Germany) Business Overview
Table 47. Evotec AG (Germany) Pharmacokinetics Services SWOT Analysis
Table 48. Evotec AG (Germany) Recent Developments
Table 49. Pacific BioLabs (US) Pharmacokinetics Services Basic Information
Table 50. Pacific BioLabs (US) Pharmacokinetics Services Product Overview
Table 51. Pacific BioLabs (US) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Pacific BioLabs (US) Business Overview
Table 53. Pacific BioLabs (US) Pharmacokinetics Services SWOT Analysis
Table 54. Pacific BioLabs (US) Recent Developments
Table 55. GVK Biosciences Private Limited (India) Pharmacokinetics Services Basic Information
Table 56. GVK Biosciences Private Limited (India) Pharmacokinetics Services Product Overview
Table 57. GVK Biosciences Private Limited (India) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. GVK Biosciences Private Limited (India) Pharmacokinetics Services SWOT Analysis
Table 59. GVK Biosciences Private Limited (India) Business Overview
Table 60. GVK Biosciences Private Limited (India) Recent Developments
Table 61. Shanghai Medicilon Inc. (China) Pharmacokinetics Services Basic Information
Table 62. Shanghai Medicilon Inc. (China) Pharmacokinetics Services Product Overview
Table 63. Shanghai Medicilon Inc. (China) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Shanghai Medicilon Inc. (China) Business Overview
Table 65. Shanghai Medicilon Inc. (China) Recent Developments
Table 66. Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Basic Information
Table 67. Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Product Overview
Table 68. Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Pharmaceutical Product Development, LLC (US) Business Overview
Table 70. Pharmaceutical Product Development, LLC (US) Recent Developments
Table 71. Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Basic Information
Table 72. Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Product Overview
Table 73. Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Charles River Laboratories International, Inc. (US) Business Overview
Table 75. Charles River Laboratories International, Inc. (US) Recent Developments
Table 76. PAREXEL International Corporation (US) Pharmacokinetics Services Basic Information
Table 77. PAREXEL International Corporation (US) Pharmacokinetics Services Product Overview
Table 78. PAREXEL International Corporation (US) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. PAREXEL International Corporation (US) Business Overview
Table 80. PAREXEL International Corporation (US) Recent Developments
Table 81. Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Basic Information
Table 82. Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Product Overview
Table 83. Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Eurofins Scientific, Inc. (Luxembourg) Business Overview
Table 85. Eurofins Scientific, Inc. (Luxembourg) Recent Developments
Table 86. Frontage Labs (US) Pharmacokinetics Services Basic Information
Table 87. Frontage Labs (US) Pharmacokinetics Services Product Overview
Table 88. Frontage Labs (US) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Frontage Labs (US) Business Overview
Table 90. Frontage Labs (US) Recent Developments
Table 91. SGS SA (Switzerland) Pharmacokinetics Services Basic Information
Table 92. SGS SA (Switzerland) Pharmacokinetics Services Product Overview
Table 93. SGS SA (Switzerland) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. SGS SA (Switzerland) Business Overview
Table 95. SGS SA (Switzerland) Recent Developments
Table 96. LGC Limited (UK) Pharmacokinetics Services Basic Information
Table 97. LGC Limited (UK) Pharmacokinetics Services Product Overview
Table 98. LGC Limited (UK) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. LGC Limited (UK) Business Overview
Table 100. LGC Limited (UK) Recent Developments
Table 101. Creative Bioarray (US) Pharmacokinetics Services Basic Information
Table 102. Creative Bioarray (US) Pharmacokinetics Services Product Overview
Table 103. Creative Bioarray (US) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Creative Bioarray (US) Business Overview
Table 105. Creative Bioarray (US) Recent Developments
Table 106. Certara, L.P. (Germany) Pharmacokinetics Services Basic Information
Table 107. Certara, L.P. (Germany) Pharmacokinetics Services Product Overview
Table 108. Certara, L.P. (Germany) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Certara, L.P. (Germany) Business Overview
Table 110. Certara, L.P. (Germany) Recent Developments
Table 111. Global Pharmacokinetics Services Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Pharmacokinetics Services Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Pharmacokinetics Services Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Pharmacokinetics Services Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Pharmacokinetics Services Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Pharmacokinetics Services Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Pharmacokinetics Services Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Pharmacokinetics Services Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Pharmacokinetics Services Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Pharmacokinetics Services Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Pharmacokinetics Services Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Pharmacokinetics Services Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Pharmacokinetics Services Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Pharmacokinetics Services Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Pharmacokinetics Services Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Pharmacokinetics Services Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Pharmacokinetics Services Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pharmacokinetics Services Market Size Comparison by Region (M USD)
Table 5. Global Pharmacokinetics Services Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Pharmacokinetics Services Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pharmacokinetics Services Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pharmacokinetics Services Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacokinetics Services as of 2022)
Table 10. Global Market Pharmacokinetics Services Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pharmacokinetics Services Sales Sites and Area Served
Table 12. Manufacturers Pharmacokinetics Services Product Type
Table 13. Global Pharmacokinetics Services Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pharmacokinetics Services
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pharmacokinetics Services Market Challenges
Table 22. Global Pharmacokinetics Services Sales by Type (K Units)
Table 23. Global Pharmacokinetics Services Market Size by Type (M USD)
Table 24. Global Pharmacokinetics Services Sales (K Units) by Type (2019-2024)
Table 25. Global Pharmacokinetics Services Sales Market Share by Type (2019-2024)
Table 26. Global Pharmacokinetics Services Market Size (M USD) by Type (2019-2024)
Table 27. Global Pharmacokinetics Services Market Size Share by Type (2019-2024)
Table 28. Global Pharmacokinetics Services Price (USD/Unit) by Type (2019-2024)
Table 29. Global Pharmacokinetics Services Sales (K Units) by Application
Table 30. Global Pharmacokinetics Services Market Size by Application
Table 31. Global Pharmacokinetics Services Sales by Application (2019-2024) & (K Units)
Table 32. Global Pharmacokinetics Services Sales Market Share by Application (2019-2024)
Table 33. Global Pharmacokinetics Services Sales by Application (2019-2024) & (M USD)
Table 34. Global Pharmacokinetics Services Market Share by Application (2019-2024)
Table 35. Global Pharmacokinetics Services Sales Growth Rate by Application (2019-2024)
Table 36. Global Pharmacokinetics Services Sales by Region (2019-2024) & (K Units)
Table 37. Global Pharmacokinetics Services Sales Market Share by Region (2019-2024)
Table 38. North America Pharmacokinetics Services Sales by Country (2019-2024) & (K Units)
Table 39. Europe Pharmacokinetics Services Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Pharmacokinetics Services Sales by Region (2019-2024) & (K Units)
Table 41. South America Pharmacokinetics Services Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Pharmacokinetics Services Sales by Region (2019-2024) & (K Units)
Table 43. Evotec AG (Germany) Pharmacokinetics Services Basic Information
Table 44. Evotec AG (Germany) Pharmacokinetics Services Product Overview
Table 45. Evotec AG (Germany) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Evotec AG (Germany) Business Overview
Table 47. Evotec AG (Germany) Pharmacokinetics Services SWOT Analysis
Table 48. Evotec AG (Germany) Recent Developments
Table 49. Pacific BioLabs (US) Pharmacokinetics Services Basic Information
Table 50. Pacific BioLabs (US) Pharmacokinetics Services Product Overview
Table 51. Pacific BioLabs (US) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Pacific BioLabs (US) Business Overview
Table 53. Pacific BioLabs (US) Pharmacokinetics Services SWOT Analysis
Table 54. Pacific BioLabs (US) Recent Developments
Table 55. GVK Biosciences Private Limited (India) Pharmacokinetics Services Basic Information
Table 56. GVK Biosciences Private Limited (India) Pharmacokinetics Services Product Overview
Table 57. GVK Biosciences Private Limited (India) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. GVK Biosciences Private Limited (India) Pharmacokinetics Services SWOT Analysis
Table 59. GVK Biosciences Private Limited (India) Business Overview
Table 60. GVK Biosciences Private Limited (India) Recent Developments
Table 61. Shanghai Medicilon Inc. (China) Pharmacokinetics Services Basic Information
Table 62. Shanghai Medicilon Inc. (China) Pharmacokinetics Services Product Overview
Table 63. Shanghai Medicilon Inc. (China) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Shanghai Medicilon Inc. (China) Business Overview
Table 65. Shanghai Medicilon Inc. (China) Recent Developments
Table 66. Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Basic Information
Table 67. Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Product Overview
Table 68. Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Pharmaceutical Product Development, LLC (US) Business Overview
Table 70. Pharmaceutical Product Development, LLC (US) Recent Developments
Table 71. Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Basic Information
Table 72. Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Product Overview
Table 73. Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Charles River Laboratories International, Inc. (US) Business Overview
Table 75. Charles River Laboratories International, Inc. (US) Recent Developments
Table 76. PAREXEL International Corporation (US) Pharmacokinetics Services Basic Information
Table 77. PAREXEL International Corporation (US) Pharmacokinetics Services Product Overview
Table 78. PAREXEL International Corporation (US) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. PAREXEL International Corporation (US) Business Overview
Table 80. PAREXEL International Corporation (US) Recent Developments
Table 81. Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Basic Information
Table 82. Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Product Overview
Table 83. Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Eurofins Scientific, Inc. (Luxembourg) Business Overview
Table 85. Eurofins Scientific, Inc. (Luxembourg) Recent Developments
Table 86. Frontage Labs (US) Pharmacokinetics Services Basic Information
Table 87. Frontage Labs (US) Pharmacokinetics Services Product Overview
Table 88. Frontage Labs (US) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Frontage Labs (US) Business Overview
Table 90. Frontage Labs (US) Recent Developments
Table 91. SGS SA (Switzerland) Pharmacokinetics Services Basic Information
Table 92. SGS SA (Switzerland) Pharmacokinetics Services Product Overview
Table 93. SGS SA (Switzerland) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. SGS SA (Switzerland) Business Overview
Table 95. SGS SA (Switzerland) Recent Developments
Table 96. LGC Limited (UK) Pharmacokinetics Services Basic Information
Table 97. LGC Limited (UK) Pharmacokinetics Services Product Overview
Table 98. LGC Limited (UK) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. LGC Limited (UK) Business Overview
Table 100. LGC Limited (UK) Recent Developments
Table 101. Creative Bioarray (US) Pharmacokinetics Services Basic Information
Table 102. Creative Bioarray (US) Pharmacokinetics Services Product Overview
Table 103. Creative Bioarray (US) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Creative Bioarray (US) Business Overview
Table 105. Creative Bioarray (US) Recent Developments
Table 106. Certara, L.P. (Germany) Pharmacokinetics Services Basic Information
Table 107. Certara, L.P. (Germany) Pharmacokinetics Services Product Overview
Table 108. Certara, L.P. (Germany) Pharmacokinetics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Certara, L.P. (Germany) Business Overview
Table 110. Certara, L.P. (Germany) Recent Developments
Table 111. Global Pharmacokinetics Services Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Pharmacokinetics Services Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Pharmacokinetics Services Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Pharmacokinetics Services Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Pharmacokinetics Services Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Pharmacokinetics Services Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Pharmacokinetics Services Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Pharmacokinetics Services Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Pharmacokinetics Services Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Pharmacokinetics Services Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Pharmacokinetics Services Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Pharmacokinetics Services Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Pharmacokinetics Services Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Pharmacokinetics Services Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Pharmacokinetics Services Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Pharmacokinetics Services Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Pharmacokinetics Services Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Pharmacokinetics Services
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmacokinetics Services Market Size (M USD), 2019-2030
Figure 5. Global Pharmacokinetics Services Market Size (M USD) (2019-2030)
Figure 6. Global Pharmacokinetics Services Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharmacokinetics Services Market Size by Country (M USD)
Figure 11. Pharmacokinetics Services Sales Share by Manufacturers in 2023
Figure 12. Global Pharmacokinetics Services Revenue Share by Manufacturers in 2023
Figure 13. Pharmacokinetics Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pharmacokinetics Services Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pharmacokinetics Services Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pharmacokinetics Services Market Share by Type
Figure 18. Sales Market Share of Pharmacokinetics Services by Type (2019-2024)
Figure 19. Sales Market Share of Pharmacokinetics Services by Type in 2023
Figure 20. Market Size Share of Pharmacokinetics Services by Type (2019-2024)
Figure 21. Market Size Market Share of Pharmacokinetics Services by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pharmacokinetics Services Market Share by Application
Figure 24. Global Pharmacokinetics Services Sales Market Share by Application (2019-2024)
Figure 25. Global Pharmacokinetics Services Sales Market Share by Application in 2023
Figure 26. Global Pharmacokinetics Services Market Share by Application (2019-2024)
Figure 27. Global Pharmacokinetics Services Market Share by Application in 2023
Figure 28. Global Pharmacokinetics Services Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pharmacokinetics Services Sales Market Share by Region (2019-2024)
Figure 30. North America Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Pharmacokinetics Services Sales Market Share by Country in 2023
Figure 32. U.S. Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Pharmacokinetics Services Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Pharmacokinetics Services Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Pharmacokinetics Services Sales Market Share by Country in 2023
Figure 37. Germany Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Pharmacokinetics Services Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Pharmacokinetics Services Sales Market Share by Region in 2023
Figure 44. China Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Pharmacokinetics Services Sales and Growth Rate (K Units)
Figure 50. South America Pharmacokinetics Services Sales Market Share by Country in 2023
Figure 51. Brazil Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Pharmacokinetics Services Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Pharmacokinetics Services Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Pharmacokinetics Services Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Pharmacokinetics Services Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pharmacokinetics Services Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pharmacokinetics Services Market Share Forecast by Type (2025-2030)
Figure 65. Global Pharmacokinetics Services Sales Forecast by Application (2025-2030)
Figure 66. Global Pharmacokinetics Services Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Pharmacokinetics Services
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmacokinetics Services Market Size (M USD), 2019-2030
Figure 5. Global Pharmacokinetics Services Market Size (M USD) (2019-2030)
Figure 6. Global Pharmacokinetics Services Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharmacokinetics Services Market Size by Country (M USD)
Figure 11. Pharmacokinetics Services Sales Share by Manufacturers in 2023
Figure 12. Global Pharmacokinetics Services Revenue Share by Manufacturers in 2023
Figure 13. Pharmacokinetics Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pharmacokinetics Services Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pharmacokinetics Services Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pharmacokinetics Services Market Share by Type
Figure 18. Sales Market Share of Pharmacokinetics Services by Type (2019-2024)
Figure 19. Sales Market Share of Pharmacokinetics Services by Type in 2023
Figure 20. Market Size Share of Pharmacokinetics Services by Type (2019-2024)
Figure 21. Market Size Market Share of Pharmacokinetics Services by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pharmacokinetics Services Market Share by Application
Figure 24. Global Pharmacokinetics Services Sales Market Share by Application (2019-2024)
Figure 25. Global Pharmacokinetics Services Sales Market Share by Application in 2023
Figure 26. Global Pharmacokinetics Services Market Share by Application (2019-2024)
Figure 27. Global Pharmacokinetics Services Market Share by Application in 2023
Figure 28. Global Pharmacokinetics Services Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pharmacokinetics Services Sales Market Share by Region (2019-2024)
Figure 30. North America Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Pharmacokinetics Services Sales Market Share by Country in 2023
Figure 32. U.S. Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Pharmacokinetics Services Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Pharmacokinetics Services Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Pharmacokinetics Services Sales Market Share by Country in 2023
Figure 37. Germany Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Pharmacokinetics Services Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Pharmacokinetics Services Sales Market Share by Region in 2023
Figure 44. China Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Pharmacokinetics Services Sales and Growth Rate (K Units)
Figure 50. South America Pharmacokinetics Services Sales Market Share by Country in 2023
Figure 51. Brazil Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Pharmacokinetics Services Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Pharmacokinetics Services Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Pharmacokinetics Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Pharmacokinetics Services Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Pharmacokinetics Services Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pharmacokinetics Services Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pharmacokinetics Services Market Share Forecast by Type (2025-2030)
Figure 65. Global Pharmacokinetics Services Sales Forecast by Application (2025-2030)
Figure 66. Global Pharmacokinetics Services Market Share Forecast by Application (2025-2030)
